Instrument/analyser IVDs
Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
Public Assessment Report
(PAR)
29-05-2020
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Available from:
Martin Flynn PTY LTD
Class:
Class 1
Manufactured by:
DRG International Inc 841 Mountain Avenue, Springfield, NJ, 07081 United States Of America
Therapeutic area:
CT943 - Instrument/analyser IVDs
Therapeutic indications:
HYB-5252 -GMDN 56718/62413 - The DRG:HYBRiD-XL? was developed for the use in Laboratories, Institutions and Doctors Practices. The DRG:HYBRID-XL? is capable of processing a broad variety of Clinical Chemistry and immunoassay. The DRG:HYBRiD-XL? is a random-access analyzer intended for professional use and must only be used by trained personnel working in compliance with the precautions for use set out in this manual and good laboratory practice (GLP).
Authorization status:
A
Authorization date:
2020-02-13
